Last reviewed · How we verify
Recombinant fimbrial adhesin dscCfaE
Recombinant fimbrial adhesin dscCfaE is a Biologic drug developed by U.S. Army Medical Research and Development Command. It is currently in Phase 1 development. Also known as: dscCfaE.
At a glance
| Generic name | Recombinant fimbrial adhesin dscCfaE |
|---|---|
| Also known as | dscCfaE |
| Sponsor | U.S. Army Medical Research and Development Command |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea (PHASE1)
- Challenge Study of an ETEC Vaccine (PHASE2)
- Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Recombinant fimbrial adhesin dscCfaE CI brief — competitive landscape report
- Recombinant fimbrial adhesin dscCfaE updates RSS · CI watch RSS
- U.S. Army Medical Research and Development Command portfolio CI
Frequently asked questions about Recombinant fimbrial adhesin dscCfaE
What is Recombinant fimbrial adhesin dscCfaE?
Recombinant fimbrial adhesin dscCfaE is a Biologic drug developed by U.S. Army Medical Research and Development Command.
Who makes Recombinant fimbrial adhesin dscCfaE?
Recombinant fimbrial adhesin dscCfaE is developed by U.S. Army Medical Research and Development Command (see full U.S. Army Medical Research and Development Command pipeline at /company/u-s-army-medical-research-and-development-command).
Is Recombinant fimbrial adhesin dscCfaE also known as anything else?
Recombinant fimbrial adhesin dscCfaE is also known as dscCfaE.
What development phase is Recombinant fimbrial adhesin dscCfaE in?
Recombinant fimbrial adhesin dscCfaE is in Phase 1.
Related
- Manufacturer: U.S. Army Medical Research and Development Command — full pipeline
- Also known as: dscCfaE
- Compare: Recombinant fimbrial adhesin dscCfaE vs similar drugs
- Pricing: Recombinant fimbrial adhesin dscCfaE cost, discount & access